1.646.889.1200|info@lifescipublicrelations.com

Catalyst gives positive hemophilia update as 2 more subjects complete study

//Catalyst gives positive hemophilia update as 2 more subjects complete study

Catalyst gives positive hemophilia update as 2 more subjects complete study

Two additional subjects completed Catalyst Biosciences’ ongoing hemophilia Phase 2/3 trial without any bleeding or developing any anti-drug antibodies (ADAs), the company said in a statement Wednesday.

By | 2018-08-16T15:03:52-04:00 August 16th, 2018|News|Comments Off on Catalyst gives positive hemophilia update as 2 more subjects complete study

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.